The Korea Times close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
Biz & Tech
  • Auto
  • IT
  • Game
  • Manufacturing
  • Retail & Food
  • Energy
  • Construction
  • Airlines
Finance
  • Policies
  • Economy
  • Markets
  • Banks
  • Non-banks
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
Lifestyle
  • Arts
  • Books
  • Travel & Cuisine
  • Trend
  • Fashion
  • Around Town
  • Fortune Telling
Entertainment
  • K-pop
  • K-dramas & Shows
  • Movies
  • Music
  • Performances
  • Asia Model Festival
Sports
  • Football
  • Golf
  • Baseball
  • Other Sports
World
  • Asia Pacific
  • Americas
  • Europe & Africa
  • SCMP
Video
  • On the Spot
  • Feature
  • News
Photos
  • Photo News
  • Darkroom
Community
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
Tue, April 13, 2021 | 00:45
Health & Welfare
2 Korean nursing home residents die after getting AstraZeneca vaccine
Posted : 2021-03-03 17:15
Updated : 2021-03-04 09:27
Mail
Print Preview
Font Size Up
Font Size Down
A medical staffer draws AstraZeneca's coronavirus vaccine from a vial into a syringe at a nursing home in Seoul, Feb. 26. Yonhap
A medical staffer draws AstraZeneca's coronavirus vaccine from a vial into a syringe at a nursing home in Seoul, Feb. 26. Yonhap

By Lee Hyo-jin

Two Gyeonggi Province nursing home residents with pre-existing conditions died Wednesday after receiving COVID-19 vaccinations, leading the health authorities to investigate whether there was any correlation between their deaths and the vaccine.

The Korea Disease Control and Prevention Agency (KDCA) said that the two residents of long-term care facilities ― one man in Goyang and the other in Pyeongtaek ― died some time after receiving their first shots of the AstraZeneca vaccine

The man at the Goyang nursing home, in his 50s, showed signs of cardiac arrest and associated breathing difficulties 11 hours after being vaccinated Tuesday morning. He received first aid on site, but died the next day due to heart failure. He had multiple pre-existing conditions including a cardiac disorder and diabetes, and had previously suffered from a stroke.

The man in Pyongtaek was a 63-year-old patient suffering from cerebrovascular disease who died four days following inoculation. After receiving his first injection Saturday afternoon, he began to show adverse reactions including a high fever and body aches the next day.

He was prescribed painkillers and a fever reducer, but was transferred to a general hospital Tuesday afternoon as his condition worsened. He died around 10 a.m., Wednesday after developing additional symptoms of sepsis and pneumonia.

"Along with the epidemiological investigation currently underway, we will thoroughly review their medical records to look into any connection between the deaths and the vaccine," KDCA Commissioner Jeong Eun-kyeong said at a briefing the same day.

She noted hundreds of deaths after vaccination have been reported in other countries but no correlations between the vaccines and the deaths have been found.

A medical staffer draws AstraZeneca's coronavirus vaccine from a vial into a syringe at a nursing home in Seoul, Feb. 26. Yonhap
A medical worker at a nursing home receives a coronavirus vaccine from AstraZeneca at a public health center in Inje, Gangwon Province, Wednesday. Yonhap

As of Tuesday, 87,428 people across the country have been vaccinated according to the KDCA. Among them, 85,904 got their first shots of the two-dose AstraZeneca vaccine, while 1,524 received their first shots of the Pfizer vaccine.

The KDCA noted that 207 abnormal reactions have been reported, most of which were minor such as headaches, fever, and vomiting. The overwhelming majority of cases ― 206 ― were reported after the administration of the AstraZeneca vaccine, and among these three were anaphylactic shock reactions.

Of the 207 severe reactions were reported involving two nursing home residents in Gyeonggi Province, also with pre-existing health conditions.

A 50-something man at a nursing home in Uijeongbu showed symptoms of dysphasia (inarticulate speech), a headache and lethargy 20 minutes after being vaccinated. He had underlying conditions of high blood pressure and diabetes.

The other man, in his 60s with a history of cerebrovascular disease and who was hospitalized at a nursing home in Pyeongtaek, reported fever, low blood pressure and muscle pain a day after inoculation.

Both were transferred to local hospitals, and are currently stable.

Meanwhile, the health authorities warned of stern measures against "line cutters" in the nationwide vaccination program, after the owner of a nursing home in Dongducheon, Gyeonggi Province, was found to have had his family members, who were not in the eligibility criteria, vaccinated.

He included his wife and also several board members of the hospital in the vaccination process for caregivers and medical workers, Feb. 26.

After conducting further investigation, the health authorities are considering filing a police complaint against him as well as taking administrative measures. Under the Infectious Disease Prevention Act, those accused of fraudulently receiving vaccination, and those involved in arranging this can be fine up to 2 million won ($1,780).


Emaillhj@koreatimes.co.kr Article ListMore articles by this reporter
Gov't to intensify monitoring of coronavirus misinformation
The South Korean government will step up efforts to contain misleading information online about coronavirus vaccines, as the country begun its mass inoculation program last week. A...









 
LG
 
  • Survivors of xenophobia, hate crime captured in photos
  • Concerns growing over deepening social divide amid pandemic
  • China's top official admits Chinese vaccines have low effectiveness
  • Concerns rise over Seoul mayor's proposed social distancing scheme
  • Teachers' portrait rights, copyright infringed on under online education
  • New virus cases back under 600 on fewer tests; curbs extended amid spring resurgence
  • Iran openly expresses discontent over frozen assets in Korea
  • Will Hyundai Card vice chairman avoid handling labor issues?
  • Seoul pushes for virus restrictions to protect small businesses
  • Korea's effort in Afghan reconstruction recognized
  • BLACKPINK's Rose sets 2 Guinness World Records with solo release BLACKPINK's Rose sets 2 Guinness World Records with solo release
  • Actress Seo Yea-ji accused of controlling boyfriend Actress Seo Yea-ji accused of controlling boyfriend
  • 'Way Back Home' follows rape survivor's path to healing from trauma 'Way Back Home' follows rape survivor's path to healing from trauma
  • Mamamoo to hold online concert on British streaming platform next month Mamamoo to hold online concert on British streaming platform next month
  • New series 'Taxi Driver' kicks off with replacement cast member New series 'Taxi Driver' kicks off with replacement cast member
DARKROOM
  • Locust outbreak

    Locust outbreak

  • Death toll rises as protests continue in Myanmar

    Death toll rises as protests continue in Myanmar

  • Say 'NO' to racism (Part 2)

    Say 'NO' to racism (Part 2)

  • Say 'NO' to racism (Part 1)

    Say 'NO' to racism (Part 1)

  • Worst dust storm chokes Beijing

    Worst dust storm chokes Beijing

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankookilbo
  • Dongwha Group